These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 11437405

  • 1. Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer.
    Helle SI, Geisler S, Aas T, Paulsen T, Holly JM, Lønning PE.
    Br J Cancer; 2001 Jul 06; 85(1):74-7. PubMed ID: 11437405
    [Abstract] [Full Text] [Related]

  • 2. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
    Johansson H, Baglietto L, Guerrieri-Gonzaga A, Bonanni B, Mariette F, Macis D, Serrano D, Sandri MT, Decensi A.
    Breast Cancer Res Treat; 2004 Nov 06; 88(1):63-73. PubMed ID: 15538047
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome.
    Vestey SB, Perks CM, Sen C, Calder CJ, Holly JM, Winters ZE.
    Breast Cancer Res; 2005 Nov 06; 7(1):R119-29. PubMed ID: 15642160
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast.
    Bohlke K, Cramer DW, Trichopoulos D, Mantzoros CS.
    Epidemiology; 1998 Sep 06; 9(5):570-3. PubMed ID: 9730040
    [Abstract] [Full Text] [Related]

  • 5. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES, Holly JM, Hunter DJ, Pollak MN, Hankinson SE.
    Endocr Relat Cancer; 2006 Jun 06; 13(2):583-92. PubMed ID: 16728584
    [Abstract] [Full Text] [Related]

  • 6. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
    Unsal E, Köksal D, Yurdakul AS, Atikcan S, Cinaz P.
    Respir Med; 2005 May 06; 99(5):559-65. PubMed ID: 15823452
    [Abstract] [Full Text] [Related]

  • 7. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer.
    Han JY, Choi BG, Choi JY, Lee SY, Ju SY.
    Lung Cancer; 2006 Nov 06; 54(2):227-34. PubMed ID: 16935391
    [Abstract] [Full Text] [Related]

  • 8. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.
    Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR.
    Cancer Epidemiol Biomarkers Prev; 2003 Aug 06; 12(8):721-7. PubMed ID: 12917202
    [Abstract] [Full Text] [Related]

  • 9. Long-term effects of fenretinide, a retinoic acid derivative, on the insulin-like growth factor system in women with early breast cancer.
    Decensi A, Johansson H, Miceli R, Mariani L, Camerini T, Cavadini E, Di Mauro MG, Barreca A, Gonzaga AG, Diani S, Sandri MT, De Palo G, Formelli F.
    Cancer Epidemiol Biomarkers Prev; 2001 Oct 06; 10(10):1047-53. PubMed ID: 11588130
    [Abstract] [Full Text] [Related]

  • 10. Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide.
    Decensi A, Veronesi U, Miceli R, Johansson H, Mariani L, Camerini T, Di Mauro MG, Cavadini E, De Palo G, Costa A, Perloff M, Malone WF, Formelli F.
    Clin Cancer Res; 2003 Oct 15; 9(13):4722-9. PubMed ID: 14581342
    [Abstract] [Full Text] [Related]

  • 11. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Baglietto L, English DR, Hopper JL, Morris HA, Tilley WD, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2007 Apr 15; 16(4):763-8. PubMed ID: 17416768
    [Abstract] [Full Text] [Related]

  • 12. Effects of tamoxifen on insulin-like growth factors, IGF binding proteins and IGFBP-3 proteolysis in breast cancer patients.
    Grønbaek H, Tanos V, Meirow D, Peretz T, Raz I, Flyvbjerg A.
    Anticancer Res; 2003 Apr 15; 23(3C):2815-20. PubMed ID: 12926118
    [Abstract] [Full Text] [Related]

  • 13. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
    Kahán Z, Gardi J, Nyári T, Földesi I, Hajnal-Papp R, Ormándi K, Lázár G, Thurzó L, Schally AV.
    Int J Oncol; 2006 Jul 15; 29(1):193-200. PubMed ID: 16773200
    [Abstract] [Full Text] [Related]

  • 14. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
    Mattsson A, Svensson D, Schuett B, Osterziel KJ, Ranke MB.
    Growth Horm IGF Res; 2008 Dec 15; 18(6):506-16. PubMed ID: 18550406
    [Abstract] [Full Text] [Related]

  • 15. Insulin-like growth factors and breast cancer risk in Chinese women.
    Yu H, Jin F, Shu XO, Li BD, Dai Q, Cheng JR, Berkel HJ, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2002 Aug 15; 11(8):705-12. PubMed ID: 12163322
    [Abstract] [Full Text] [Related]

  • 16. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
    Fleming JM, Leibowitz BJ, Kerr DE, Cohick WS.
    J Endocrinol; 2005 Jul 15; 186(1):165-78. PubMed ID: 16002546
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA, Borofsky ND, Massardo S, Orentreich N.
    Cancer Epidemiol Biomarkers Prev; 2002 Dec 15; 11(12):1566-73. PubMed ID: 12496045
    [Abstract] [Full Text] [Related]

  • 18. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F, McKay JD, Cleveland RJ, Dossus L, Biessy C, Boillot C, Rinaldi S, Llewellyn M, Chajès V, Clavel-Chapelon F, Téhard B, Chang-Claude J, Linseisen J, Lahmann PH, Pischon T, Trichopoulos D, Trichopoulou A, Zilis D, Palli D, Tumino R, Vineis P, Berrino F, Bueno-de-Mesquita HB, van Gils CH, Peeters PH, Pera G, Barricarte A, Chirlaque MD, Quirós JR, Larrañaga N, Martínez-García C, Allen NE, Key TJ, Bingham SA, Khaw KT, Slimani N, Norat T, Riboli E, Kaaks R.
    Cancer Epidemiol Biomarkers Prev; 2005 Oct 15; 14(10):2316-25. PubMed ID: 16214911
    [Abstract] [Full Text] [Related]

  • 19. Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein I in breast cancer patients.
    Lønning PE, Hall K, Aakvaag A, Lien EA.
    Cancer Res; 1992 Sep 01; 52(17):4719-23. PubMed ID: 1380889
    [Abstract] [Full Text] [Related]

  • 20. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
    Rinaldi S, Kaaks R, Zeleniuch-Jacquotte A, Arslan AA, Shore RE, Koenig KL, Dossus L, Riboli E, Stattin P, Lukanova A, Toniolo P.
    Cancer Epidemiol Biomarkers Prev; 2005 Jan 01; 14(1):48-52. PubMed ID: 15668475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.